Ignite Creation Date:
2025-12-25 @ 5:01 AM
Ignite Modification Date:
2025-12-26 @ 4:02 AM
Study NCT ID:
NCT02230618
Status:
COMPLETED
Last Update Posted:
2018-03-13
First Post:
2014-08-29
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Post Marketing Surveillance (PMS) Study of Ryzodeg™ (Insulin Degludec/Insulin Aspart) in Patients With Diabetes Mellitus in Routine Clinical Practice in India
Sponsor:
Novo Nordisk A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-11-24
Start Date Type:
ACTUAL
Primary Completion Date:
2017-06-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-06-01
Completion Date Type:
ACTUAL
First Submit Date:
2014-08-29
First Submit QC Date:
None
Study First Post Date:
2014-09-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-03-12
Last Update Post Date:
2018-03-13
Last Update Post Date Type:
ACTUAL